DARZALEX 20 mg/mL concentrate for solution for infusion | medicines.ie

Company: Janssen Sciences Ireland (a Johnson & Johnson Company)
Active Ingredient: Daratumumab
Strength: Daratumumab: 100 mg
Dosage Form: Concentrate for solution for infusion
Legal Category: A - prescription, may not be renewed
Last Updated: 25/09/2026

Licence numbers with strength, ATC code and dosage form
Licence number	Strength	ATC Code	Dosage Form
EU/1/16/1101/001	100 mg	L01XC24	Concentrate for solution for infusion
EU/1/16/1101/002	100 mg	L01XC24	Concentrate for solution for infusion

Licence number: EU/1/16/1101/001
Strength: 100 mg
ATC Code: L01XC24
Dosage Form: Concentrate for solution for infusion

Licence number: EU/1/16/1101/002
Strength: 100 mg
ATC Code: L01XC24
Dosage Form: Concentrate for solution for infusion

Janssen Sciences Ireland (a Johnson & Johnson Company)

Janssen Sciences Ireland UC, Barnahely, Ringaskiddy, IRL - Co. Cork P43 FA46, P43 FA46 Ringaskiddy

Website: https://innovativemedicine.jnj.com/ireland/
Telephone: +3531800709122
Email: medinfo@its.jnj.com